Drug Trial Radar · NCT03000348
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
Last checked: Nov 19, 2026Latest source record: Apr 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
91
Actual
Start
Dec 2016
Primary completion
Apr 2018
Study completion Apr 2018
Sponsor
- Lead sponsor
- NovaBiotics Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Agility Clinical, Inc.; PSR Group B.V.
- First posted
- Dec 22, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study investigates the use of cysteamine in the treatment of adults with Cystic Fibrosis who are experiencing an exacerbation of CF-associated lung disease. There are six different potential dosing regimens, including one that is placebo.
Conditions
- Cystic Fibrosis
Interventions
CysteamineDrug
Oral Cysteamine Capsule
Placebo Oral CapsuleDrug
Placebo Oral Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Sputum Bacterial LoadTime frame: Baseline through Day 21/End of Study
- Safety and Tolerability Assessed by the Number of Subjects With Adverse EventsTime frame: Baseline through Day 21/End of Study
Locations
17 sites in 3 countries. Site status is shown where the registry gives one.
Banner University of Arizona Medical Center
Tucson, Arizona
San Francisco Critical Care Medical Group California Pacific Medical Center
San Francisco, California
University of Florida
Gainesville, Florida
Central Florida Pulmonary
Orlando, Florida
Albany Medical College
Albany, New York
Nationwide Children's Hospital
Columbus, Ohio
West Virginia University
Morgantown, West Virginia
The Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin
Ospedale Padiatrico Bambino Gesu Centro Fibrosi Cistica
Roma, Italy
Azienda Ospedaliera Universitaria Integrato di Verona Borgo Trento Centro Fibrosi Cistica
Verona, Italy
Ninewells Hospital Scottish Adult Cystic Fibrosis Service
Dundee, United Kingdom
Western General Hospital Edinburgh, CF Adults / CF Unit
Edinburgh, United Kingdom
NHS GGC
Glasgow, United Kingdom
Raigmore Hospital
Inverness, United Kingdom
St. James University Hospital
Leeds, United Kingdom
Royal Victoria Infirmary Adult CF Centre
Newcastle upon Tyne, United Kingdom
Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.